News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WILLIAMS DOUGLAS E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2023 |
4
| WILLIAMS DOUGLAS E (President & CEO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 465,000 options to buy
@ $0.74, valued at
$344.1k
|
|
| 01/23/2023 |
4
| WILLIAMS DOUGLAS E (See Remarks) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 5,075 shares
@ $0.575, valued at
$2.9k
Exercised 13,667 restricted stock units
@ $0 |
|
| 02/18/2022 |
4
| WILLIAMS DOUGLAS E (President & CEO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 61,250 options to buy
@ $5.21, valued at
$319.1k
Granted 91,875 restricted stock units
@ $0 |
|
| 01/21/2022 |
4
| WILLIAMS DOUGLAS E (President & CEO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.21, valued at
$1.4M
Granted 41,000 restricted stock units
@ $0 |
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| WILLIAMS DOUGLAS E (President & CEO) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 175,000 options to buy
@ $26.6, valued at
$4.7M
|
|
| 10/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 13,250 options to buy
@ $5.29, valued at
$70.1k
|
|
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 5,813 options to buy
@ $1.6, valued at
$9.3k
|
|
| 04/03/2019 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Disposed/sold 4,056 shares
@ $0 |
|
| 08/16/2018 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Bought 5,000 shares
@ $6.4883, valued at
$32.4k
|
|
| 06/08/2018 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 5,813 options to buy
@ $8.12, valued at
$47.2k
|
|
| 06/04/2018 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 16,223 shares
@ $0 |
|
| 06/02/2017 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 15,625 shares
@ $0 |
|
| 06/03/2016 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 36,620 options to buy
@ $6.2, valued at
$227k
|
|
| 06/03/2016 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 23,674 shares
@ $0 |
|
| 06/26/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/22/2015 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 3,841 shares
@ $410, valued at
$1.6M
|
|
| 06/05/2015 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 16,556 shares
@ $0 |
|
| 02/25/2015 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Granted 8,300 restricted stock units
@ $0 |
|
| 02/17/2015 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,683 shares
@ $392.11, valued at
$659.9k
Paid exercise price by delivering 767 shares
@ $392.11, valued at
$300.7k
Exercised 3,573 restricted stock units
@ $0
Exercised 1,627 restricted stock units
@ $0
Disposed of 1,041 restricted stock units
@ $0 |
|
| 02/10/2015 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,634 shares
@ $402, valued at
$656.9k
Exercised 3,468 restricted stock units
@ $0 |
|
| 02/02/2015 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 2,059 shares
@ $389.16, valued at
$801.3k
Exercised 5,157 restricted stock units
@ $0 |
|
| 06/05/2014 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 19,778 shares
@ $0 |
|
| 05/22/2014 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Regulus Therapeutics Inc.|
Txns:
| Granted 17,500 options to buy
@ $6.22, valued at
$108.9k
|
|
| 03/21/2014 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Sold 1,595 shares
@ $352.29, valued at
$561.9k
Sold 916 shares
@ $352.29, valued at
$322.7k
Sold 994 shares
@ $352.29, valued at
$350.2k
|
|
| 02/14/2014 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,685 shares
@ $323.04, valued at
$544.3k
Exercised 3,573 restricted stock units
@ $0
Granted 8,010 restricted stock units
@ $0 |
|
| 02/11/2014 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,636 shares
@ $315.54, valued at
$516.2k
Exercised 3,468 restricted stock units
@ $0 |
|
| 02/03/2014 |
4
| WILLIAMS DOUGLAS E (EVP Research & Development) has filed a Form 4 on BIOGEN IDEC INC.|
Txns:
| Paid exercise price by delivering 1,969 shares
@ $312.64, valued at
$615.6k
Exercised 5,159 restricted stock units
@ $0 |
|
| 08/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/08/2012 |
4
| WILLIAMS DOUGLAS E (Director) has filed a Form 4 on Regulus Therapeutics Inc. |
| 06/08/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|